GB2368523A - Solid wound healing formulations containing fibronectin - Google Patents

Solid wound healing formulations containing fibronectin

Info

Publication number
GB2368523A
GB2368523A GB0203693A GB0203693A GB2368523A GB 2368523 A GB2368523 A GB 2368523A GB 0203693 A GB0203693 A GB 0203693A GB 0203693 A GB0203693 A GB 0203693A GB 2368523 A GB2368523 A GB 2368523A
Authority
GB
United Kingdom
Prior art keywords
wound healing
formulations containing
fibronectin
solid wound
containing fibronectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0203693A
Other versions
GB2368523B (en
GB0203693D0 (en
Inventor
Andre Beaulieu
Robert Paquin
Benoit Lariviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB0203693D0 publication Critical patent/GB0203693D0/en
Publication of GB2368523A publication Critical patent/GB2368523A/en
Application granted granted Critical
Publication of GB2368523B publication Critical patent/GB2368523B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

A concentrated solution of a wound healing promoter, in particular fibronectin, is used to develop solid wound dressings. The solid wound dressings containing fibronectin are easy to apply, easy to remove, and deliver fibronectin in a range of physiologically active dosages.
GB0203693A 1999-08-20 2000-08-21 Solid wound healing formulations containing fibronectin Expired - Fee Related GB2368523B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14995899P 1999-08-20 1999-08-20
US18241200P 2000-02-14 2000-02-14
PCT/CA2000/000953 WO2001013967A1 (en) 1999-08-20 2000-08-21 Solid wound healing formulations containing fibronectin

Publications (3)

Publication Number Publication Date
GB0203693D0 GB0203693D0 (en) 2002-04-03
GB2368523A true GB2368523A (en) 2002-05-08
GB2368523B GB2368523B (en) 2004-05-12

Family

ID=26847182

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203693A Expired - Fee Related GB2368523B (en) 1999-08-20 2000-08-21 Solid wound healing formulations containing fibronectin

Country Status (7)

Country Link
EP (1) EP1210130A1 (en)
JP (1) JP2003507440A (en)
AU (1) AU781865B2 (en)
CA (1) CA2380730A1 (en)
GB (1) GB2368523B (en)
MX (1) MXPA02001576A (en)
WO (1) WO2001013967A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002361902A1 (en) * 2001-12-31 2003-07-24 Ares Medical, Inc. Hemostatic compositions and methods for controlling bleeding
BRPI0716270A2 (en) 2006-08-28 2013-08-13 Rexaderm Inc dry wound bandage and drug delivery system
JP5724108B2 (en) * 2009-04-22 2015-05-27 メドスキン ソリューションズ ドクター ズベラック アーゲーＭｅｄＳｋｉｎ Ｓｏｌｕｔｉｏｎｓ Ｄｒ．Ｓｕｗｅｌａｃｋ ＡＧ Lyophilized composition
JP2020070270A (en) * 2018-11-01 2020-05-07 御木本製薬株式会社 Fibronectin gene expression promoter
CN113577378A (en) * 2021-08-28 2021-11-02 上海纤瑞生物技术有限公司 Fibronectin liquid wound spray dressing and preparation method and application thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784989A (en) * 1982-09-14 1988-11-15 Hoeoek Magnus Means for removing microorganisms from tissue
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
EP0572272A1 (en) * 1992-05-29 1993-12-01 JOHNSON & JOHNSON MEDICAL, INC. Absorbable bone sealant
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin
WO1998012228A1 (en) * 1996-09-19 1998-03-26 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates
US5877149A (en) * 1995-06-07 1999-03-02 Beaulieu; Andre Deepithelialized skin diffusion cell system
WO1999027167A1 (en) * 1997-11-26 1999-06-03 Intercytex Limited Process for the production of protein fibres and products thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124155A (en) * 1988-06-21 1992-06-23 Chiron Ophthalmics, Inc. Fibronectin wound-healing dressings

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784989A (en) * 1982-09-14 1988-11-15 Hoeoek Magnus Means for removing microorganisms from tissue
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
EP0572272A1 (en) * 1992-05-29 1993-12-01 JOHNSON & JOHNSON MEDICAL, INC. Absorbable bone sealant
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin
US5877149A (en) * 1995-06-07 1999-03-02 Beaulieu; Andre Deepithelialized skin diffusion cell system
WO1998012228A1 (en) * 1996-09-19 1998-03-26 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates
WO1999027167A1 (en) * 1997-11-26 1999-06-03 Intercytex Limited Process for the production of protein fibres and products thereof

Also Published As

Publication number Publication date
JP2003507440A (en) 2003-02-25
MXPA02001576A (en) 2004-08-12
EP1210130A1 (en) 2002-06-05
WO2001013967A1 (en) 2001-03-01
GB2368523B (en) 2004-05-12
AU781865B2 (en) 2005-06-16
CA2380730A1 (en) 2001-03-01
AU6676300A (en) 2001-03-19
GB0203693D0 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
SE9701162D0 (en) New use II
MY129356A (en) Electrospun pharmaceutical compositions
EP1143950A3 (en) Topical application products
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
GB0105772D0 (en) Use
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
IL154210A0 (en) Methods and pharmaceutical compositions for healing wounds
WO2000064405A3 (en) Treating hair by targeting enzymes
EP1310256A3 (en) Use of prostaglandin A or its derivatives for the treatment of psoriasis
WO2002053090A3 (en) Medicinal association of a biguanine (metformin) and arginine
CA2231176A1 (en) Long active composition for rectal administration
DE60016798D1 (en) PAPERTOOK CONTAINING ANTIVIRAL ACTIVE SUBSTANCES, WHICH ARE SKIN-FRIENDLY
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
GB2368523A (en) Solid wound healing formulations containing fibronectin
WO2002036090A3 (en) Cosmetic plaster for bleaching the skin
GB9708692D0 (en) Dermal sheath tissue and/or cells derived therefrom in wound healing
AU2001291731A1 (en) Pharmaceutical, effervescent formulation containing ramipril
DK0951294T3 (en) Wound healing formulations containing human plasma fibronectin
GEP20043231B (en) Resorcinol Composition
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
IS5231A (en) Tissue factor affecting blood vessels
WO2000002601A3 (en) Transdermal delivery system
ES2156731A1 (en) Use of tranexamic acid for the preparation of a human fibrinogen composition
AU2002236587A1 (en) Compositions for adhesion prevention

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20060821